BRII-B(02137) released its annual performance, with a net loss attributable to shareholders of 223 million yuan, a year-on-year decrease of 56.19%.

19:04 19/03/2026

Tengsheng Bo Medicine-B (02137) announced its annual performance for the year ending December 31, 2025. The company achieved a revenue of 18.605 million yuan (same unit), compared to zero revenue for the same period last year. The company's owners' share of losses for the year amounted to 223 million yuan, a decrease of 56.19% compared to the previous year. Loss per share was 0.31 yuan.

BRII-B (02137) announced its annual performance ending on December 31, 2025. The company generated a profit of 18.605 million yuan (units are the same), compared to zero profit in the same period last year. The company's owners' share of the annual loss decreased by 56.19% year-on-year to 223 million yuan, with a loss per share of 0.31 yuan. The announcement stated that the increase in profit was mainly attributed to the payments received under the intellectual property license and technology transfer agreement with Joincare Pharmaceutical Group Industry group.

SIS MOBILE (01362) announces 2025 performance, net profit of HK$6,634,000, a year-on-year decrease of 32.42%.

CNBM(03323): Sinoma Science & Technology (002080.SZ) achieved a net profit attributable to the parent company of 1.818 billion yuan in 2025, a year-on-year increase of 103.82%.

NOAH HOLDINGS (06686) spent approximately $376,000 on March 18 to repurchase 162,520 shares.

SIS MOBILE (01362) announces 2025 performance, net profit of HK$6,634,000, a year-on-year decrease of 32.42%.

CNBM(03323): Sinoma Science & Technology (002080.SZ) achieved a net profit attributable to the parent company of 1.818 billion yuan in 2025, a year-on-year increase of 103.82%.

NOAH HOLDINGS (06686) spent approximately $376,000 on March 18 to repurchase 162,520 shares.